The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Drug adherence in hypertension: from methodological issues to cardiovascular outcomes
Open accessAbstract
: Adherence to treatment is now well recognized as a crucial key in the effectiveness of antihypertensive drugs; however, it is often overlooked in the management of hypertension because methodology to assess it is partly unreliable and limits its use in clinical practice. The available evidence suggests that nonadherence is highly prevalent in a chronic asymptomatic condition such as hypertension. It may undermine benefits expected from antihypertensive agents and therefore, may negatively impact cardiovascular, cerebrovascular and renal outcomes. In this review, we discuss the methodological issues related to the measurement of drug adherence in a research setting and clinical practice, the prevalence and the impact of drug nonadherence on blood pressure control and thus in apparent resistant hypertension, and on cardiovascular, cerebrovascular and renal outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, since non-adherence prevails, hypertension is not under desirable control [10, 11].”
From The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877
RetractedOsterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,399
A systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 1×
“[70], in a meta-analysis, showed effectively a reduction of risk of mortality in patients with high adherence to the active drug therapy and even to the placebo.”
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,212
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
Wolf-Maier, K., Cooper, R., Kramer, H., Banegas, J. R., Giampaoli, S., Joffres, M. R., Poulter, N. R., Primatesta, P., Stegmayr, B., & Thamm, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000103630.72812.10 · Cited by 1,081
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F. H., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,077
Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
Bangalore, S., Kamalakkannan, G., Parkar, S., & Messerli, F. H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.033 · Cited by 1,075
How often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,032
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht295 · Cited by 931
Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
Daugherty, S. L., Powers, J. D., Magid, D. J., Tavel, H. M., Masoudi, F. A., Margolis, K. L., O'Connor, P. J., Selby, J. V., & Ho, P. M. (2012) · Circulation · doi:10.1161/circulationaha.111.068064 · Cited by 930
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 778
Poulter, N. R., Prabhakaran, D., & Caulfield, M. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61468-9 · Cited by 730
The Coronary Drug Project Research Group (1980) · New England Journal of Medicine · doi:10.1056/nejm198010303031804 · Cited by 659
Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.9.652 · Cited by 585
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. T., Cain, E., Cordeiro-Breault, M., Canning, C. F., & Platt, R. G. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Azizi, M., Sapoval, M., Gosse, P., Monge, M., Bobrie, G., Delsart, P., Midulla, M., Mounier-Véhier, C., Courand, P.-Y., Lantelme, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61942-5 · Cited by 519
Self-citationRaebel, M. A., Schmittdiel, J. A., Karter, A. J., Konieczny, J. L., & Steiner, J. F. (2013) · Medical Care · doi:10.1097/mlr.0b013e31829b1d2a · Cited by 488
Granger, B. B., Swedberg, K. B., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J. V., Yusuf, S., Michelson, E. L., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67760-4 · Cited by 475
Resistant hypertension? Assessment of adherence by toxicological urine analysis
Jung, O., Gechter, J. L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., & Toennes, S. W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835e2286 · Cited by 474
Treatment adherence and risk of death after a myocardial infarction
Horwitz, R. I., Viscoli, C. M., Donaldson, R. M., Murray, C. J. L., Ransohoff, D. F., Horwitz, R. I., Berkman, L. F., Horwitz, S. M., Ransohoff, D. F., & Sindelar, J. L. (1990) · The Lancet · doi:10.1016/0140-6736(90)92095-y · Cited by 453
Heusser, K., Tank, J., Engeli, S., Diedrich, A., Menne, J., Eckert, S., Peters, T., Sweep, F. C. G. J., Haller, H., Pichlmaier, A. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140665 · Cited by 433
Krousel-Wood, M. A., Thomas, S., Muntner, P., & Morisky, D. E. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000126978.03828.9e · Cited by 417
How Can We Improve Adherence to Blood Pressure–Lowering Medication in Ambulatory Care?
Schroeder, K., Fahey, T. P., & Ebrahim, S. B. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.722 · Cited by 409
PIERDOMENICO, S., LAPENNA, D., BUCCI, A., DITOMMASO, R., DIMASCIO, R., MANENTE, B., CALDARELLA, M., NERI, M., CUCCURULLO, F., & MEZZETTI, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.014 · Cited by 409
Tomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., Samani, N. J., Gupta, P., Madira, W., Stanley, A., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305063 · Cited by 404
Bramley, T. J., Nightengale, B. S., Frech-Tamas, F., & Gerbino, P. P. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.3.239 · Cited by 380
Validation of pharmacy records in drug exposure assessment
Lau, H. S., de Boer, A., Beuning, K. S., & Porsius, A. J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00040-1 · Cited by 371
Better compliance to antihypertensive medications reduces cardiovascular risk
Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328342ca97 · Cited by 367
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
Burnier, M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.006 · Cited by 356
Measuring concurrent adherence to multiple related medications.
Choudhry, N. K., Shrank, W. H., Levin, R., Lee, J. L.-Y., Jan, S. A., Brookhart, M. A., & Solomon, D. H. (2009) · PubMed · Cited by 342
Continuation of initial antihypertensive medication after 1 year of therapy.
Bloom, B. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80130-6 · Cited by 324
Monane, M. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00056-3 · Cited by 276
Burnier, M., Schneider, M. P., Chioléro, A., Stubi, C.-L. F., & Brunner, H. R. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00022 · Cited by 264
Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts
Garg, J. P., ELLIOTT, W., Folker, A., Izhar, M., & Black, H. R. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.021 · Cited by 258
Measuring, Analyzing, and Managing Drug Adherence in Resistant Hypertension
Burnier, M., Wuerzner, G., Struijker-Boudier, H., & Urquhart, J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00687 · Cited by 229
Cost of poor adherence to anti-hypertensive therapy in five European countries
Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M. G., Gray, A. R., Lévy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A. P., et al. (2014) · The European Journal of Health Economics · doi:10.1007/s10198-013-0554-4 · Cited by 217
Elmula, F. E. M. F., Hoffmann, P., Larstorp, A. C. K., Fossum, E., Brekke, M., Kjeldsen, S. E., Gjønnæss, E., Hjørnholm, U., Kjær, V. N., Rostrup, M., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03246 · Cited by 209
Sim, J. J., Bhandari, S. K., Shi, J., Liu, I. L. A., Calhoun, D. A., McGlynn, E. A., Kalantar-Zadeh, K., & Jacobsen, S. J. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.06.017 · Cited by 206
Resistant Hypertension in a Tertiary Care Clinic
Yakovlevitch, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090078014 · Cited by 184
Kronish (2011) · doi:10.1161/circulationaha.110.983874 · Cited by 182
Therapeutic Drug Monitoring Facilitates Blood Pressure Control in Resistant Hypertension
Brinker, S. K., Pandey, A., Ayers, C., Price, A. L., Raheja, P., Arbique, D., Das, S. R., Halm, E., Kaplan, N., & Vongpatanasin, W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.067 · Cited by 181
Detection and Treatment of Hypertension at the Work Site
Alderman, M. H., & Schoenbaum, E. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507102930203 · Cited by 178
Facts and fiction of poor compliance as a cause of inadequate blood pressure control
Wetzels, G., Nelemans, P. J., Schouten, J., & Prins, M. H. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00002 · Cited by 172
Ceral, J., Habrdová, V., Voříšek, V., Bima, M., Pelouch, R., & Solař, M. (2010) · Hypertension Research · doi:10.1038/hr.2010.183 · Cited by 170
Štrauch, B., Petrák, O., Zelinka, T., Rosa, J., Krátká, Z., Indra, T., Chytil, L., Marešová, V., Kurcová, I., Holaj, R., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283652c61 · Cited by 165
Drug Side Effect Symptoms and Adherence to Antihypertensive Medication
Tedla, Y. G., & Bautista, L. E. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv185 · Cited by 162
Factors Associated with Drug Adherence and Blood Pressure Control in Patients with Hypertension
Morris, A. B., Li, J., Kroenke, K., Bruner-England, T. E., Young, J. M., & Murray, M. D. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.4.483 · Cited by 154
Kettani, F., Dragomir, A., Côté, R., Roy, L. F., Bérard, A., Blais, L., Lalonde, L., Moreau, P. R., & Perreault, S. (2008) · Stroke · doi:10.1161/strokeaha.108.522193 · Cited by 154
Azizi, M., Pereira, H., Hamdidouche, I., Gosse, P., Monge, M., Bobrie, G., Delsart, P., Mounier‐Véhier, C., Courand, P., Lantelme, P., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022922 · Cited by 154
Self-citationNew drugs, procedures, and devices for hypertension
Laurent, S., Schlaich, M. P., & Esler, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60825-3 · Cited by 151
Self-citationDiabetes Empowerment, Medication Adherence and Self-Care Behaviors in Adults with Type 2 Diabetes
Hernandez‐Tejada, M. A., Campbell, J. A., Walker, R. J., Smalls, B. L., Davis, K. S., & Egede, L. E. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0287 · Cited by 145
Measuring Adherence in a Hypertension Clinical Trial
Hamilton, G. A. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00058-6 · Cited by 144
In Search of the Gold Standard for Compliance Measurement
Rudd, P. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630430009004 · Cited by 133
Dynamics of drug regimen compliance ? its assessment by microprocessor-based monitoring
Kruse, W., & Weber, E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278582 · Cited by 131
Nüesch, R., Schroeder, K., Dieterle, T., Martina, B., & Battegay, E. J. (2001) · BMJ · doi:10.1136/bmj.323.7305.142 · Cited by 120
Pharmaceutical care of patients with heart failure
Sadik, A., Yousif, M. A., & McElnay, J. C. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02387.x · Cited by 114
Poor Adherence to Placebo or Amiodarone Therapy Predicts Mortality
Irvine, J., Baker, B., Smith, J. L., Jandciu, S., Paquette, M., Cairns, J. A., Connolly, S. J., Roberts, R., Gent, M., & Dorian, P. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199907000-00023 · Cited by 113
Pladevall, M., Brotons, C., Gabriel, R., Arnau, A., Suárez, C., de la Figuera, M., Marquez, E., Coca, A., Sobrino, J., Divine, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.892778 · Cited by 109
Daugherty, S. L., Powers, J. D., Magid, D. J., Masoudi, F. A., Margolis, K. L., O’Connor, P. J., Schmittdiel, J. A., & Ho, P. M. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.192096 · Cited by 109
Pandey, A., Raza, F. S., Velasco, A., Brinker, S., Ayers, C. R., Das, S. R., Morisky, D. E., Halm, E. A., & Vongpatanasin, W. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.04.004 · Cited by 108
Validity of four indirect methods to measure adherence in primary care hypertensives
Prado, J. C., Kupek, E., & Mion, D. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002196 · Cited by 106
Improving on a Coin Toss To Predict Patient Adherence to Medications
Turner, B. J., & Hecht, F. M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00015 · Cited by 97
Predictors of uncontrolled hypertension and antihypertensive medication nonadherence
Macedo, A. F., Morgado, M., Castelo-Branco, M., Rolo, S., & Pereira, L. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.74263 · Cited by 95
Andréjak, M., Genes, N., Vaur, L., Poncelet, P., Clerson, P., & Carre, A. G. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00175-2 · Cited by 93
Hameed, M. A., Tebbit, L., Jacques, N., Thomas, M., & Dasgupta, I. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.38 · Cited by 83
Ewen, S., Meyer, M. R., Cremers, B., Laufs, U., Helfer, A. G., Linz, D., Kindermann, I., Ukena, C., Burnier, M., Wagenpfeil, S., et al. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0905-5 · Cited by 83
Factors involved in the discontinuation of antihypertensive drug therapy
Mancia, G., Zambon, A., Soranna, D., Merlino, L. G., & Corrao, G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000222 · Cited by 81
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment‐Resistant Hypertension
Irvin, M. R., Shimbo, D., Mann, D. M., Reynolds, K., Krousel-Wood, M. A., Limdi, N. A., Lackland, D. T., Calhoun, D. A., Oparil, S., & Muntner, P. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00690.x · Cited by 80
Physicians’ Ability to Predict Patients’ Adherence to Antihypertensive Medication in Primary Care
Zeller, A., Taegtmeyer, A. B., Martina, B. E. E., Battegay, E., & Tschudi, P. (2008) · Hypertension Research · doi:10.1291/hypres.31.1765 · Cited by 78
Zeng, F., Patel, B. V., Andrews, L., Frech‐Tamas, F., & Rudolph, A. E. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.534129 · Cited by 73
Adherence level of antihypertensive agents in coronary artery disease
Perreault, S., Dragomir, A., Roy, L. F., White, M., Blais, L., Lalonde, L., & Bérard, A. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03547.x · Cited by 72
Schmieder, R. E., Ott, C., Schmid, A., Friedrich, S., Kistner, I., Ditting, T., Veelken, R. A., Uder, M., & Toennes, S. W. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002343 · Cited by 69
Better adherence to antihypertensive agents and risk reduction of chronic heart failure
Perreault, S., Dragomir, A., White, M., Lalonde, L., Blais, L., & Bérard, A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02084.x · Cited by 69
Intensive Monitoring of Adherence to Treatment Helps to Identify “True” Resistant Hypertension
de SOUZA, W. A., Sabha, M., Favero, F. D. F., Bergsten‐Mendes, G., Yugar‐Toledo, J. C., & Moreno, H. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00102.x · Cited by 55
Florczak, E., Tokarczyk, B., Warchoł-Celińska, E., Szwench-Pietrasz, E., Prejbisz, A., Gosk-Przybyłek, M., Kabat, M., Narkiewicz, K., Januszewicz, A., & Kała, M. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2648 · Cited by 42
Azizi, M., Ménard, J., Peyrard, S., Lièvre, M. M., Marre, M., & Châtellier, G. (2006) · Diabetes Care · doi:10.2337/dc06-0255 · Cited by 38
Self-citationBeaussier, H., Boutouyrie, P., Bobrie, G., Frank, M., Laurent, S., Coudoré, F., & Azizi, M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000737 · Cited by 38
Self-citationElectronic monitoring of adherence, treatment of hypertension, and blood pressure control.
van Onzenoort, H. V., Verberk, W., Kroon, A., Kessels, A., Neef, C., van der Kuy, P. M., & de Leeuw, P. D. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.153 · Cited by 36
Therapeutic strategies to improve control of hypertension
Armario, P., & Waeber, B. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835d2c6c · Cited by 36
Foran, J. P., Jain, A., Casserly, I. P., Kandzari, D. E., Rocha‐Singh, K. J., Witkowski, A., Katzen, B. T., Deaton, D., Balmforth, P., & Sobotka, P. A. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25707 · Cited by 32
Hodge, R. H., LYNCH, S. S., Davison, J., Knight, J. G., Sinn, J. A., & Carey, R. M. (1979) · Hypertension · doi:10.1161/01.hyp.1.5.537 · Cited by 5
Cited by
Sorted by citations
Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
Burnier, M., & Egan, B. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313220 · Cited by 878
Nonadherence to antihypertensive drugs: A systematic review and meta-analysis
Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017) · Medicine · doi:10.1097/md.0000000000005641 · Cited by 525
Medication adherence among patients with apparent treatment-resistant hypertension
Durand, H., Hayes, P., Morrissey, E. C., Newell, J., Casey, M., Murphy, A. W., & Molloy, G. J. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001502 · Cited by 198
Lee, E. K. P., Poon, P. K.-M., Yip, B. H. K., Bo, Y., Zhu, M., Yu, C., Ngai, A. C. H., Wong, M. C. S., & Wong, S. Y. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026582 · Cited by 196
Hamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s368784 · Cited by 212
Metadata
- Authors
- Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Laurent, Stéphane
- Venue
- Journal of Hypertension
- Published
- 2017-06
- Volume
- 35
- Issue
- 6
- Pages
- 1133-1144
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2596282637
- Cited by
- 111
- References
- 88
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 16 · 2021: 18 · 2020: 14 · 2019: 16 · 2018: 16 · 2017: 8
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- cc-by-nc-nd
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- medication adherence, hypertension, antihypertensive drugs, adherence measurement methods, blood pressure control, resistant hypertension, cardiovascular outcomes, cerebrovascular outcomes, renal outcomes
- MeSH terms
- Assessment of Medication Adherence, Antihypertensive Agents, Cardiovascular System, Humans, Hypertension, Kidney, Biomarkers, Drug Monitoring, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review